Advance Medical Weight Loss
205 Glastonbury Boulevard · Glastonbury, CT 06033
Retatrutide isn't available here yet. These are practices that treat weight and metabolic health, and some prescribe FDA-approved GLP-1s today. Inclusion does not mean a provider offers retatrutide.
205 Glastonbury Boulevard · Glastonbury, CT 06033
330 Western Boulevard · Glastonbury, CT 06033
140 Glastonbury Boulevard · Glastonbury, CT 06033
4.9(282 Google reviews · 28 in past year)
99 Citizens Drive · Glastonbury, CT 06033
4.9(204 Google reviews · 36 in past year)
2951 Main Street · Glastonbury, CT 06033
4.6(87 Google reviews · 25 in past year)
69 Eastern Boulevard · Glastonbury, CT 06033
4.7(63 Google reviews · 39 in past year)
36 Welles Street · Glastonbury, CT 06033
4.9(62 Google reviews · 8 in past year)
39 New London Turnpike · Glastonbury, CT 06033
5.0(54 Google reviews · 37 in past year)
701 Hebron Avenue · Glastonbury, CT 06033
4.5(53 Google reviews · 18 in past year)
100 Sycamore Street · Glastonbury, CT 06033
5.0(25 Google reviews · 10 in past year)
212 New London Turnpike · Glastonbury, CT 06033
5.0(20 Google reviews · 4 in past year)
155 Sycamore Street · Glastonbury, CT 06033
4.3(6 Google reviews · 2 in past year)
2790 Main Street · Glastonbury, CT 06033
5.0(3 Google reviews · 1 in past year)
330 Western Boulevard · Glastonbury, CT 06033
1.0(1 Google review · 1 in past year)
Pins reflect street addresses where available; others are approximate (ZIP-level).
Be first to know when its status changes — join thousands already on the list.
No. Retatrutide is investigational and not FDA-approved, so it is not available by prescription in Glastonbury or anywhere else in the U.S. The only legitimate routes today are clinical trials and Lilly's expanded access program, where your physician applies on your behalf and medical criteria must be met. RetaMaps tracks the status and the local providers most relevant to future treatment.
They are practices in medical weight management, obesity medicine, endocrinology, metabolic health, and related fields. Some currently advertise FDA-approved GLP-1 medications such as semaglutide or tirzepatide; each profile shows what the practice publicly advertises today.
Yes — 6 of the 18 tracked providers in this market indicate telehealth visits. State licensing rules determine whether a given telehealth practice can serve Connecticut residents; confirm with the practice.
No. Inclusion on RetaMaps does not mean a provider offers or will offer retatrutide — and no legitimate provider can prescribe it today. Where a practice has told RetaMaps directly that it expects to offer retatrutide if approved, we mark that clearly on its profile.
Join the RetaMaps update list with your email and ZIP. We'll email when retatrutide's regulatory or commercial status changes relevant to your area. It's informational — not a treatment queue.